Drug-resistance development differs between HIV-1-infected patients failing first-line antiretroviral therapy containing nonnucleoside reverse transcriptase inhibitors with and without thymidine analogues-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Drug-resistance development differs between HIV-1-infected patients failing first-line antiretroviral therapy containing nonnucleoside reverse transcriptase inhibitors with and without thymidine analogues

Published:2013-05-13 Issue:9 Volume:14 Page:571-577
ISSN:1464-2662
Container-title:HIV Medicine
language:en
Short-container-title:HIV Med

Author:

Santoro MM¹,Sabin C²,Forbici F³,Bansi L²,Dunn D⁴,Fearnhill E⁴,Boumis E³,Nicastri E³,Antinori A³,Palamara G⁵,Callegaro A⁶,Francisci D⁷,Zoncada A⁸,Maggiolo F⁶,Zazzi M⁹,Perno CF¹³,Ceccherini-Silberstein F¹,Mussini C¹⁰

Affiliation:

1. University of Rome Tor Vergata; Rome Italy

2. University College London; London UK

3. INMI L Spallanzani Hospital; Rome Italy

4. MRC Clinical Trials Unit; London UK

5. IRCSS San Gallicano; Rome Italy

6. Ospedali Riuniti; Bergamo Italy

7. Clinic of Infectious Diseases; Perugia Italy

8. Cremona Hospital; Cremona Italy

9. University of Siena; Siena Italy

10. Modena University Hospital; Modena Italy

Publisher

Wiley

Subject

Pharmacology (medical),Infectious Diseases,Health Policy

Reference19 articles.

1. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies;The Antiretroviral Therapy Cohort Collaboration;Lancet,2008

2. The incidence of HIV drug resistance and its impact on progression of HIV disease among antiretroviral-naive participants started on three different antiretroviral therapy strategies;Kozal;HIV Clin Trials,2007

3. Emergence of drug resistance is associated with an increased risk of death among patients first starting HAART;Hogg;PLoS Med,2006

4. Recommendations of the International AIDS Society USA Panel;Antiretroviral Treatment of Adult HIV Infection;JAMA,2010

5. European AIDS Clinical Society Guidelines (EACS) Guidelines for the Clinical Management and Treatment of HIV infected adults in Europe 2011

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of the M184V resistance mutation on treatment outcomes in patients with HIV infection: a systematic review and meta-analysis;Aids Reviews;2023-10-20

2. Impact of archived M184V/I mutation on the effectiveness of switch to co-formulated elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide among virally suppressed people living with HIV;Journal of Antimicrobial Chemotherapy;2020-07-31

3. Accumulation of HIV-1 Drug Resistance Mutations After First-Line Immunological Failure to Evaluate the Options of Recycling NRTI Drugs in Second-Line Treatment: A Study from South India;AIDS Research and Human Retroviruses;2017-03

4. Prevalence of K65R in patients treated with tenofovir disoproxil fumarate: recommendations based on the Frankfurt HIV Cohort Study Resistance Database (FHCS-RD);MED MICROBIOL IMMUN;2016

5. Focus on Chirality of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors;Molecules;2016-02-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3